Hims & Hers Health (HIMS) Non-Current Assets (2019 - 2026)
Hims & Hers Health (HIMS) posted Non-Current Assets of $1.2 billion for Q1 2026, down 11.92% sequentially from $1.4 billion in Q4 2025, and up 174.69% YoY from $444.7 million in Q1 2025.
Hims & Hers Health (HIMS) Non-Current Assets (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Non-Current Assets for 8 years, with the latest figure at $1.2 billion in Q1 2026.
- Quarterly Non-Current Assets rose 174.69% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 billion (up 269.81% YoY) and the FY2025 annual result came in at $1.4 billion, up 344.99% from the prior year.
- Non-Current Assets fell to $1.2 billion in Q1 2026 per HIMS's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $1.4 billion in Q3 2025 and troughed at $149.4 million in Q3 2022.
- A 5-year average of $421.9 million and a median of $186.4 million in 2024 frame the typical range for Non-Current Assets.
- The widest YoY moves for Non-Current Assets: up 2531.36% in 2022, down 0.62% in 2022.
- Over 5 years, Non-Current Assets stood at $149.7 million in 2022, then advanced by 17.62% to $176.1 million in 2023, then surged by 76.97% to $311.7 million in 2024, then soared by 344.99% to $1.4 billion in 2025, then retreated by 11.92% to $1.2 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.2 billion, $1.4 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 2.24 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.24 Bn |
| Mar 31, 2026 | 1.22 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.39 Bn |
| Jun 30, 2025 | 522.02 Mn |
| Mar 31, 2025 | 444.75 Mn |
| Dec 31, 2024 | 311.71 Mn |
| Sep 30, 2024 | 275.89 Mn |
| Jun 30, 2024 | 189.58 Mn |
| Mar 31, 2024 | 186.37 Mn |
| Dec 31, 2023 | 176.13 Mn |
| Sep 30, 2023 | 163.65 Mn |
| Jun 30, 2023 | 155.24 Mn |
| Mar 31, 2023 | 150.78 Mn |
| Dec 31, 2022 | 149.75 Mn |
| Sep 30, 2022 | 149.37 Mn |
| Jun 30, 2022 | 149.48 Mn |
| Mar 31, 2022 | 150.09 Mn |
| Dec 31, 2021 | 150.68 Mn |
| Sep 30, 2021 | 145.84 Mn |